Table 3.

Intracranial efficacy and failed sites of progression of patients with BMS who were previously treated with or without brain RT

	With prior RT	Without prior RT	p value
IORR, %	25	31.3	0.999
IDCR, %	50	43.8	0.723
iPFS, month	2.2	2.2	0.949
OS, month	14.8	NR	0.856
Failed sites of progression, n			0.034
Intracranial	4	2
Extracranial	5	2
Both	5	8

NR not reached